Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: Assessment of prevalence, impact of national guidance, and practice-To-practice variability

Clinical Chemistry

Volumn 58, Issue 5, 2012, Pages 906-915

  Driskell, Owen J ^a   Holland, David ^b   Hanna, Fahmy W ^a   Jones, Peter W ^c   Pemberton, R John ^d   Tran, Martin ^a   Fryer, Anthony A ^a,c  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b National Pathology Benchmarking Service   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d DIABETES UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE;

DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE;

EID: 84860701117     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.176487     Document Type: Article

References (24)

1. Department of Health. Independent review of NHS pathology services. http://www.dh.gov.uk/ab/Archive/IRNHSPS/index.htm?ssSourceSiteId-en (Accessed April 2012).
2. Rao GG, Crook M, Tillyer ML. Pathology tests: Is the time for demand management ripe at last? J Clin Pathol 2003;56:243-8. (Pubitemid 36459791)
3. Janssens PMW. Managing the demand for laboratory testing: Options and opportunities. Clin Chim Acta 2010;411:1596-602.
4. Davis P, Gribben B, Lay-Yee R, Scott A. How much variation in clinical activity is there between general practitioners? A multi-level analysis of decision-making in primary care. J Health Serv Res Policy 2002;7:202-8.
5. Leurquin P, Van Casteren V, De Maeseneer J. Use of blood tests in general practice: A collaborative study in eight European countries. Eurosentinel Study Group. Br J Gen Pract 1995;45:21-5.
6. Mindemark M, Wernroth L, Larsson A. Costly regional variations in primary health care test utilization in Sweden. Scand J Clin Lab Invest 2010;70:164-70.
7. O'Kane MJ, Casey L, Lynch PLM, McGowan N, Corey J. Clinical outcome indicators, disease prevalence and test request variability in primary care. Ann Clin Biochem 2011;48:155-8.
8. Dine CJ, Bellini LM, Iwashyna TJ. Team effect on variation in laboratory utilization on subspecialty services. Acad Med 2009;84(10 Suppl):S63-6.
9. American Diabetes Association. Standards of medical care in diabetes: 2011. Diabetes Care 2011;34(Suppl 1):S11-61.
10. National Institute for Health and Clinical Excellence. Type 1 diabetes (CG15). http://guidance. nice.org.uk/CG15 (Accessed August 2011).
11. National Institute for Health and Clinical Excellence. Type 2 diabetes (CG66). http://guidance. nice.org.uk/CG66 (Accessed August 2011).
12. Canadian Diabetes Association. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1). http://www.diabetes.ca/files/cpg2008/ cpg-2008.pdf (Accessed December 2011).
13. Fryer AA, Hanna FW. Managing demand for pathology tests: Financial imperative or duty of care? Ann Clin Biochem 2009;46:435-7.
14. National Institute for Health and Clinical Excellence. Clinical Knowledge Summaries: Diabetes type 2-management. http://www.cks.nhs.uk/diabetes-Type-2 (Accessed April 2012).
15. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station, TX: Stata Press; 2005.
16. Lyon AW, Higgins T, Wesenberg JC, Tran DV, Cembrowski GS. Variation in frequency of haemoglobin A1c (HbA1c) testing: Population studies used to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes. J Diabetes Sci Technol 2009;3: 411-7.
17. Salvagno GL, Lippi G. Targher G, Montagnana M, Guidi GC. Monitoring glycaemic control: Is there evidence for appropriate use of routine measurement of glycated haemoglobin? Clin Chem Lab Med 2007;45:1065-7. (Pubitemid 47424860)
18. Van Walraven C, Maymond M, for the Network of Eastern Ontario Medical Laboratories (NEO-MeL). Population-based study of repeat laboratory testing. Clin Chem 2003;49:1997-2005.
19. Akan P, Cimrin D, Ormen M, Kume T, Ozkaya A, Ergor G, Abacioglu H. The inappropriate use of HbA1c testing to monitor glycaemia: Is there evidence in laboratory data? J Eval Clin Pract 2007;13:21-4. (Pubitemid 46238792)
20. Rankin D, Heller S, Lawton J. Understanding information and education gaps among people with type 1 diabetes: A qualitative investigation. Patient Educ Couns 2011;83:87-91.
21. Alonso-Cerezo MC, Martin JS, Garcia Montes MA, de la Iglesia VM. Appropriate utilization of clinical laboratory tests. Clin Chem Lab Med 2009;47:1461-5.
22. Smellie WS, Finnigan DI, Wilson D, Freedman D, McNulty CA, Clark G. Methodology for constructing guidance. J Clin Pathol 2005;58:249-53.
23. Fu C, Ji L, Wang W, Luan R, Chen W, Zhan S, Xu B. Frequency of HbA1c monitoring was inversely associated with glycemic control of patients with type 2 diabetes mellitus. J Endocrinol Invest [Epub ahead of print 2011 May 23].
24. Turchin A, Goldberg SI, Breydo E, Shubina M, Einbinder JS. Copy/paste documentation of lifestyle counselling and glycemic control in patients with diabetes: True to form? Arch Intern Med 2011;171:1393-4.